Primer: Niox Group (NIOX LN) - Mar 2026
Niox Group is a market leader in the niche of Fractional Exhaled Nitric Oxide (FeNO) testing for asthma diagnosis and management, with its NIOX...
Circassia Pharmaceuticals - Joining the dots
Circassia’s recent interims demonstrated 55% y-o-y revenue growth to £28.4m and a 75% R&D expense reduction (to £6.9m from £27.2m in H117)...
No more insights